Daxor showcases blood volume analyzer at MedAxiom CV Transforum
DXR•Daxor will demonstrate its FDA-cleared Blood Volume Analyzer platform at MedAxiom’s CV Transforum Fall ’26 in Denver on October 22-24, 2026. The company says the platform operates three times faster than its predecessor, uses 50% less sample volume and delivers greater than 95% measurement accuracy.
1. Conference demonstration
Daxor will attend MedAxiom’s CV Transforum Fall ’26 in Denver, Colorado, October 22-24, 2026. Its commercial leaders will demonstrate the FDA-cleared next-generation Blood Volume Analyzer platform to cardiovascular executives, focusing on clinical integration and institutional returns.
2. Platform performance
Daxor says the platform operates three times faster than its predecessor, requires 50% less sample volume and delivers greater than 95% measurement accuracy.
